pFRLuc-CoV2-WT
(Plasmid
#177614)
-
PurposeDual luciferase reporter for SARS-CoV-2 programmed -1 ribosomal frameshifting
-
Depositing Lab
-
Sequence Information
Ordering
Item | Catalog # | Description | Quantity | Price (USD) | |
---|---|---|---|---|---|
Plasmid | 177614 | Standard format: Plasmid sent in bacteria as agar stab | 1 | $85 |
Backbone
-
Vector backbonepmirGLO
-
Backbone manufacturerPromega
-
Modifications to backboneReplaced FLuc stop codon, MCS, SV40 poly(A) signal, and SV40 promoter with FSE
-
Vector typeMammalian Expression, Luciferase
-
Selectable markersNeomycin (select with G418)
Growth in Bacteria
-
Bacterial Resistance(s)Ampicillin, 100 μg/mL
-
Growth Temperature37°C
-
Growth Strain(s)DH5alpha
-
Copy numberHigh Copy
Gene/Insert
-
Gene/Insert nameSARS-CoV-2 FSE
-
SpeciesSARS-CoV-2
-
Insert Size (bp)86
Resource Information
-
Supplemental Documents
Terms and Licenses
-
Academic/Nonprofit Terms
-
Industry Terms
- Not Available to Industry
Trademarks:
- Zeocin® is an InvivoGen trademark.
These plasmids were created by your colleagues. Please acknowledge the Principal Investigator, cite the article in which the plasmids were described, and include Addgene in the Materials and Methods of your future publications.
-
For your Materials & Methods section:
pFRLuc-CoV2-WT was a gift from Junjie Guo (Addgene plasmid # 177614 ; http://n2t.net/addgene:177614 ; RRID:Addgene_177614) -
For your References section:
Restriction of SARS-CoV-2 replication by targeting programmed -1 ribosomal frameshifting. Sun Y, Abriola L, Niederer RO, Pedersen SF, Alfajaro MM, Silva Monteiro V, Wilen CB, Ho YC, Gilbert WV, Surovtseva YV, Lindenbach BD, Guo JU. Proc Natl Acad Sci U S A. 2021 Jun 29;118(26). pii: 2023051118. doi: 10.1073/pnas.2023051118. 10.1073/pnas.2023051118 PubMed 34185680